2-49154446-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The ENST00000419927.1(FSHR):​n.-29G>A variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.29 in 1,609,736 control chromosomes in the GnomAD database, including 70,533 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.29 ( 6505 hom., cov: 31)
Exomes 𝑓: 0.29 ( 64028 hom. )

Consequence

FSHR
ENST00000419927.1 non_coding_transcript_exon

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 0.730

Publications

102 publications found
Variant links:
Genes affected
FSHR (HGNC:3969): (follicle stimulating hormone receptor) The protein encoded by this gene belongs to family 1 of G-protein coupled receptors. It is the receptor for follicle stimulating hormone and functions in gonad development. Mutations in this gene cause ovarian dysgenesis type 1, and also ovarian hyperstimulation syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2010]
FSHR Gene-Disease associations (from GenCC):
  • ovarian hyperstimulation syndrome
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • ovarian dysgenesis 1
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • 46 XX gonadal dysgenesis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.5).
BP6
Variant 2-49154446-C-T is Benign according to our data. Variant chr2-49154446-C-T is described in ClinVar as Benign. ClinVar VariationId is 137403.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.457 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FSHRNM_000145.4 linkc.-29G>A 5_prime_UTR_variant Exon 1 of 10 ENST00000406846.7 NP_000136.2
FSHRNM_181446.3 linkc.-29G>A 5_prime_UTR_variant Exon 1 of 9 NP_852111.2
FSHRXM_011532733.3 linkc.-29G>A 5_prime_UTR_variant Exon 1 of 11 XP_011531035.1
FSHRXM_011532740.1 linkc.-29G>A 5_prime_UTR_variant Exon 1 of 11 XP_011531042.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FSHRENST00000406846.7 linkc.-29G>A 5_prime_UTR_variant Exon 1 of 10 1 NM_000145.4 ENSP00000384708.2

Frequencies

GnomAD3 genomes
AF:
0.286
AC:
43353
AN:
151800
Hom.:
6493
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.251
Gnomad AMI
AF:
0.275
Gnomad AMR
AF:
0.369
Gnomad ASJ
AF:
0.225
Gnomad EAS
AF:
0.473
Gnomad SAS
AF:
0.351
Gnomad FIN
AF:
0.271
Gnomad MID
AF:
0.190
Gnomad NFE
AF:
0.275
Gnomad OTH
AF:
0.286
GnomAD2 exomes
AF:
0.322
AC:
80116
AN:
249064
AF XY:
0.315
show subpopulations
Gnomad AFR exome
AF:
0.256
Gnomad AMR exome
AF:
0.489
Gnomad ASJ exome
AF:
0.219
Gnomad EAS exome
AF:
0.478
Gnomad FIN exome
AF:
0.272
Gnomad NFE exome
AF:
0.270
Gnomad OTH exome
AF:
0.287
GnomAD4 exome
AF:
0.290
AC:
422620
AN:
1457818
Hom.:
64028
Cov.:
33
AF XY:
0.291
AC XY:
210771
AN XY:
725280
show subpopulations
African (AFR)
AF:
0.248
AC:
8279
AN:
33378
American (AMR)
AF:
0.473
AC:
21107
AN:
44634
Ashkenazi Jewish (ASJ)
AF:
0.216
AC:
5645
AN:
26110
East Asian (EAS)
AF:
0.480
AC:
19040
AN:
39664
South Asian (SAS)
AF:
0.342
AC:
29445
AN:
86122
European-Finnish (FIN)
AF:
0.278
AC:
14835
AN:
53340
Middle Eastern (MID)
AF:
0.255
AC:
1059
AN:
4158
European-Non Finnish (NFE)
AF:
0.276
AC:
305882
AN:
1110274
Other (OTH)
AF:
0.288
AC:
17328
AN:
60138
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
14024
28048
42071
56095
70119
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10468
20936
31404
41872
52340
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.286
AC:
43405
AN:
151918
Hom.:
6505
Cov.:
31
AF XY:
0.288
AC XY:
21363
AN XY:
74240
show subpopulations
African (AFR)
AF:
0.252
AC:
10425
AN:
41440
American (AMR)
AF:
0.370
AC:
5642
AN:
15264
Ashkenazi Jewish (ASJ)
AF:
0.225
AC:
780
AN:
3468
East Asian (EAS)
AF:
0.473
AC:
2430
AN:
5140
South Asian (SAS)
AF:
0.349
AC:
1678
AN:
4808
European-Finnish (FIN)
AF:
0.271
AC:
2857
AN:
10554
Middle Eastern (MID)
AF:
0.197
AC:
58
AN:
294
European-Non Finnish (NFE)
AF:
0.275
AC:
18682
AN:
67934
Other (OTH)
AF:
0.286
AC:
603
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
1573
3145
4718
6290
7863
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
450
900
1350
1800
2250
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.273
Hom.:
7336
Bravo
AF:
0.294
Asia WGS
AF:
0.423
AC:
1467
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Mar 20, 2014
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Ovarian dysgenesis 1 Benign:1
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to rule this variant out of causing disease. Therefore, this variant is classified as benign. -

Ovarian hyperstimulation syndrome Benign:1
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.50
CADD
Benign
12
DANN
Benign
0.89
PhyloP100
0.73
PromoterAI
-0.018
Neutral
Mutation Taster
=300/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1394205; hg19: chr2-49381585; COSMIC: COSV58618032; COSMIC: COSV58618032; API